Jordan Pharmaceuticals & Healthcare Report Q3 2014: New Research Report Available at Fast Market Research
This quarter has seen the extension of GlaxoSmithKline's bribery allegation investigations. These now span the Gulf Levant, bringing Jordan's pharmaceutical industry into the spotlight. We do not believe Jordan will attract interest from innovative drugmakers in 2014 and project low single-digit growth in the market. This growth forecast is based on our expectations for weak government spending, the JFDA's recent medicine price cuts and weak pharmaceutical import growth in 2013.
View full press release